Ian Ganly

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

89h-index31.4kcitations765works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(176), Thyroid Cancer Diagnosis and Treatment(161), Salivary Gland Tumors Diagnosis and Treatment(146), Head and Neck Surgical Oncology(100), Virus-based gene therapy research(74)

Publications751 total

Organ Preservation for Nasal Cavity Cancers Using Definitive Radiotherapy for Avoiding Rhinectomy
JAMA Oncology·2025Open Access
Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure
Head & Neck·2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC
Otolaryngology·2025Open Access
Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors
Surgery·2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)
International Journal of Radiation Oncology*Biology*Physics·2025· 1 cited
The Use of Proton Radiation in the Management of Adenoid Cystic Carcinoma
International Journal of Particle Therapy·2025Open Access
Flap Complications Following Maxillectomy, Reconstructive Surgery, and Postoperative Proton Radiotherapy: A Cohort Study and Considerations for Risk Mitigation
Head & Neck·2025
Predictors of Osteoradionecrosis following Post-Operative Intensity-Modulated Radiation Therapy and Proton Therapy for Oral Cavity Cancer
International Journal of Radiation Oncology*Biology*Physics·2025
Non-Operative Management of Nasal Cavity Cancers with Definitive Proton Beam Therapy or Intensity Modulated Radiation Therapy for Organ Preservation
International Journal of Radiation Oncology*Biology*Physics·2025
LONG-TERM OUTCOMES FOLLOWING SUBSTANTIAL DE-ESCALATION OF ELECTIVE RADIOTHERAPY DOSE AND VOLUME IN PATIENTS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY FOR HUMAN PAPILLOMAVIRUS-ASSOCIATED OROPHARYNGEAL CANCER
Radiotherapy and Oncology·2025
Osteoradionecrosis as a Complication Following Intensity-Modulated Radiation Therapy or Proton Therapy in the Treatment of Oropharyngeal Carcinoma
International Journal of Radiation Oncology*Biology*Physics·2025
Long-Term Outcomes Following Substantial De-Escalation of Elective Radiotherapy Dose and Volume in Patients Treated with Definitive Chemoradiotherapy for HPV-Associated Oropharyngeal Cancer
International Journal of Radiation Oncology*Biology*Physics·2025
Outcome of Partial Laryngeal vs. Whole Laryngeal Radiation for Early Stage T1-2N0 Laryngeal Carcinoma.
International Journal of Radiation Oncology*Biology*Physics·2025
The Influence of Chemo-Radiotherapy Dose and Radiotherapy Volumes on Peripheral Immunity in HPV+ Oropharyngeal Cancer
International Journal of Radiation Oncology*Biology*Physics·2025
Osteoradionecrosis as a complication following post-operative intensity-modulated radiation therapy or proton therapy for oral cavity cancer
Oral Oncology·2025· 6 cited
Long-Term Outcomes Following Immediate Dental Implant Placement in Free Fibula Flaps for Oncologic Mandibular Reconstruction
Journal of Reconstructive Microsurgery·2025
Updated Calcitonin Values for Prediction of Lymph Node Metastasis in Medullary Thyroid Cancer
JAMA Otolaryngology–Head & Neck Surgery·2025· 1 cited
Expanding the histologic spectrum of thyroid neoplasms with NTRK1/2/3 or ALK translocation: a single-center retrospective study of 82 cases
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2025· 1 citedOpen Access
Clinical and surgical outcomes of neoadjuvant targeted therapy in anaplastic and differentiated thyroid cancer.
Journal of Clinical Oncology·2025· 2 cited
Osteoradionecrosis as a complication following intensity-modulated radiation therapy or proton therapy in the treatment of oropharyngeal carcinoma.
Journal of Clinical Oncology·2025· 2 cited
page 1 of 38Next →

Frequent Co-authors

Jatin P. Shah(21), Snehal G. Patel(21), Luc G.T. Morris(20), Timothy A. Chan(13), Ronald Ghossein(13), Ashok R. Shaha(11), Richard J. Wong(10), James A. Fagin(8), R. Michael Tuttle(8), Bhuvanesh Singh(8), Nadeem Riaz(7), Nora Katabi(7), Nancy Y. Lee(7), Frank L. Palmer(7), Aneel Bhangu(7), Jocelyn Migliacci(6), Iain J. Nixon(6), Dennis H. Kraus(6), Stephanie Eng(5), Iñigo Landa(5)